HENRY A MCKINNELL
CIK 1174453 · CEO and Chairman of the Board · last filed 2022-05-24
HENRY A MCKINNELL is a CEO and Chairman of the Board who has filed 116 SEC Form 4 insider transactions across 8 companies since 2007. The most recent filing, for CCXI, was dated May 24, 2022. Across all open-market trades the lifetime net is +$2.0M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $109.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$109.32M
8
116
$1.98M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CCXI | Director | 72,749 | $14.54 | $1.06M | $0 | 8 | 2022-05-24 |
| MCO | Director | 89,487 | $484.35 | $43.34M | $0 | 78 | 2021-03-19 |
| Federal Street Acquisition Corp. (FSACW) Delisted | Director | 25,000 | — | — | $0 | 1 | 2019-01-04 |
| ViewRay, Inc. (VRAY) Delisted | Director | 689,046 | $0.03 | $17.2K | $1.98M | 8 | 2019-01-03 |
| ANGIOTECH PHARMACEUTICALS INC (ANPI) Delisted | Director | — | — | — | $0 | 2 | 2009-12-14 |
| ANGIOTECH PHARMACEUTICALS INC (JRT) Delisted | Director | — | — | — | $0 | 2 | 2008-12-15 |
| XOM | Director | 36,400 | $153.28 | $5.58M | $0 | 2 | 2007-04-03 |
| PFE | Director | 2,347,539 | $25.27 | $59.33M | $0 | 5 | 2007-03-02 |
Recent Filings
116 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-05-24 | CCXI | Exer (M) | +7,726 | $0 | EDGAR |
| 2021-05-24 | CCXI | Grant (A) | — | $0 | EDGAR |
| 2021-03-19 | MCO | Grant (A) | +125 | $36.1K | EDGAR |
| 2021-02-23 | MCO | Grant (A) | +650 | $179.9K | EDGAR |
| 2020-12-16 | MCO | Grant (A) | +110 | $30.7K | EDGAR |
| 2020-09-11 | MCO | Grant (A) | +104 | $30.1K | EDGAR |
| 2020-06-11 | MCO | Grant (A) | +110 | $30.3K | EDGAR |
| 2020-05-26 | CCXI | Grant (A) | +4,660 | $0 | EDGAR |
| 2020-03-20 | MCO | Grant (A) | +161 | $27.2K | EDGAR |
| 2020-02-21 | MCO | Grant (A) | +892 | $250.1K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.